Log In
Print
BCIQ
Print
Print this Print this
 

IBI-10090

  Manage Alerts
Collapse Summary General Information
Company Icon Bioscience Inc.
DescriptionUndisclosed anti-inflammatory agent delivered using Verisome technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationCataract
Indication DetailsReduce inflammation after cataract surgery
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today